Amid overwhelming public demand for alternative COVID-19 vaccines, IHH Singapore officially began offering its first batch of 10,000 doses of the Sinopharm COVID-19 vaccine on 30 August.
With this first batch of 10,000 doses offered across Gleneagles Hospital, Mount Elizabeth Hospital and Parkway Shenton clinics in Duxton and One Raffles Quay, IHH Singapore is able to inoculate some 5,000 people.
Dr Noel Yeo, Chief Operating Officer of IHH Healthcare Singapore, said that more than 6,000 individuals had registered their interest to receive the Sinopharm vaccine even before it was made available.
"We were aware there is a demand for alternative vaccines. However, the response for Sinopharm has been overwhelming. We are making plans for second orders but we have to clear approvals from HSA (Health Sciences Authority) first,” he said.
For those looking for alternative vaccines, the Sinopharm vaccine has a reported higher efficacy rate compared to the Sinovac vaccine - 79 per cent compared to 51 per cent - and reportedly milder side effects.
Related Stories
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme
Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.
IHH Healthcare Wins Four Awards for Leadership and Learning Excellence
IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.
